Claim Missing Document
Check
Articles

Found 3 Documents
Search
Journal : Medula

Hubungan Tahap Pengobatan dengan Kualitas Hidup Pasien Multidrug-resistant Tuberculosis di RSUD Dr. H. Abdul Moeloek Provinsi Lampung Muhammad Rifki Pratama; Asep Sukohar; Khairun Nisa Berawi
Medula Vol 10 No 1 (2020): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v10i1.48

Abstract

Tuberculosis (TB) is the number one infectious disease in the world as the most frequent cause of death. TB infects 10 million people each year and becomes the 10th highest cause of death in the world.Multidrug-resistant Tuberculosis (MDR-TB) is a type of TB germ resistance against at least two first-line anti-tuberculosis (OAT) drugs. MDR-TB treatment certainly takes longer than 18 months. This very long treatment can affect the quality of life of MDR-TB patients. This study is to determine the correlation between the treatment phases with the quality of life of patients with Multidrug-resistant Tuberculosis in Dr. H. Abdul Moeloek Hospital Lampung Province. This study used 68 respondents who had been diagnosed with MDR-TB by pulmonary specialists. Primary data was taken using SF-36 questionnaire to measure the quality of life of MDR-TB patients, then secondary data based on the treatment phases using the medical record of the patient who had filled out the questionnaire. The data is processed and analyzed by the program in the computer. Data were tested by chi-square test and the results were obtained from 30 respondents in the initial treatment phases, 22 people (73.3%) quality of life was poor and 8 people had good quality of life (26.7%), while from 38 respondents at the continued treatment phases, as many as 12 people (31.6%) quality of life is bad and 26 people have good quality of life (68.4%). The result of bivariate analysis showed the variable had a correlation with p-value=0,001. There is a correlation between the treatment phases with the quality of life of patients with Multidrug-resistant Tuberculosis in RSUD Dr. H. Abdul Moeloek.
Manfaat Terapi Plasma Konvalesen pada Infeksi Covid-19 Asep Sukohar; Zihan Zetira
Medula Vol 10 No 2 (2020): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v10i2.76

Abstract

The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has attracted the world’s attention. On June the cases spreaded more than 200 countries and territories. America occupied the highest level of confirmed cases 4.437.946 and fatality cases 119.761. In Indonesia has 47.898 confirmed cases and 2.535 fatality cases. Until now there are no specific drugs or vaccines available to treat COVID-19. The principle therapy in Indonesia are oxygen supplementation, fluid theraphy, vasopressor drugs, empiric antibiotic, symptomatic therapy, and systemic corticosteroid. The Food and Drug Administration (FDA) recommends therapy in patients COVID-19 are use convalescent plasma taken from patients who recovered from infection. Convalescent plasma therapy is the administration of passive polyclonal antibodies (Ab) to provide immediate immunity that has been used more than a century ago. Several studies have reported that the use of convalescent plasma increases patient survival, improves clinical symptoms, decreases mortality and there are no significant adverse effects.
Medication Error pada Tahap Prescribing, Transcribing, Dispensing dan Administration Eka Ananda Laksana Putri; Asep Sukohar; Ervina Damayanti
Medula Vol 13 No 4 (2023): Medula
Publisher : CV. Jasa Sukses Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53089/medula.v13i4.667

Abstract

Medication Error is any error that occurs in the treatment process, endangers the patient and can actually be prevented. According to WHO, the number of incidents of medication errors shows that this is a global problem. This error occurs both in the process of prescribing (prescribing), reading the prescription (transcribing), preparation to drug delivery (dispensing), as well as in the process of drug use (administering). In this journal review, issues related to Medication Errors are collected and then reviewed again to see definitions, terminology, events, influencing factors, ways of prevention and legal consequences related to Medication Errors. Medication error can be a very fundamental clinical problem. Factors that influence Medication Error include the complexity of clinical cases, lack of knowledge of doctors and pharmacists, factors related to drugs, communication, workload and unsupportive work systems. In prevention, pharmacists have an important role because they collaborate directly with doctors who write prescriptions. Automation and computers, rules and policies, standards and protocols, checklists and double check systems, and greater caution and vigilance can be used to reduce medication Error. Patients are protected by law because they are consumers of health services. The relationship between doctors and patients involves legal aspects, namely civil and criminal. Criminal law only applies to errors and negligence if the patient dies or becomes disabled as a result of the medical treatment provided whereas civil lawsuits can be filed when the patient suffers a loss even if the fault is minor.